Author | Tianhong Li, MD, PhD | OncLive

Author | Tianhong Li, MD, PhD

Articles

Dr. Li Reviews Afatinib Data From the LUX-Lung 3 Trial

January 17, 2013

Video

Tianhong (Tina) Li, MD, PhD, from the UC Davis Comprehensive Cancer Center, discusses results from the LUX-Lung 3 trial that examined afatinib as a first-line treatment for patients with EGFR-positive advanced lung adenocarcinoma.

Dr. Li Describes the Future of Lung Cancer Therapy

September 19, 2011

Video

Dr. Tianhong Li from University of California Davis Cancer Center Describes the Future of Lung Cancer Therapy

Dr. Li Discusses the EML4-ALK Fusion Gene

September 09, 2011

Video

Dr. Tianhong Li from UC Davis Cancer Center Discusses the EML4-ALK Fusion Gene

Dr. Li Discusses the PROFILE Crizotinib Clinical Trials

September 01, 2011

Video

Dr. Tianhong Li from UC Davis Cancer Center Discusses the PROFILE Crizotinib Clinical Trials

x